Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Soonbum Kwon
Observed name:
Kwon, Soonbum
Institution:
Celltrion (South Korea)
Observed institutions:
Seoul National University,
Celltrion (South Korea)
ORCID:
0000-0002-0517-8647
Observed ORCID:
0000-0002-0517-8647
OpenAlex ID:
A5058626401
Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells
2018
·
Duc-Hiep Bach
, Donghwa Kim
, et al.
·
Molecular Therapy — Nucleic Acids
·
82
PDF
Mitochondria-targeting indolizino[3,2-c]quinolines as novel class of photosensitizers for photodynamic anticancer activity
2018
·
Soonbum Kwon
, Yeongcheol Lee
, et al.
·
European Journal of Medicinal Chemistry
·
57
Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells
2017
·
Huong Thuy Le
, Huy Truong Nguyen
, et al.
·
Cancer Letters
·
43
Indolizino[3,2-c]quinolines as environment-sensitive fluorescent light-up probes for targeted live cell imaging
2017
·
Soonbum Kwon
, Dah In Kwon
, et al.
·
Sensors and Actuators B Chemical
·
15
Asymmetric Total Synthesis of (+)-Intricenyne via an Endocyclization Route to Oxocane Skeleton
2017
·
Jungmin Ahn
, Changjin Lim
, et al.
·
Organic Letters
·
6
Corrigendum to “Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells” [Canc. Lett. 412 (2018) 297-307]
2018
·
Huong Thuy Le
, Huy Truong Nguyen
, et al.
·
Cancer Letters
·
5
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea
2023
·
Jae-Cheol Jo
, Youngwoo Jeon
, et al.
·
Expert Opinion on Biological Therapy
·
3
Long-term results of a randomized controlled trial of biosimilar CT-P16 and reference bevacizumab in patients with metastatic or recurrent non-small cell lung cancer
2025
·
Zoran Andric
, Fedor Moiseenko
, et al.
·
Cancer Treatment and Research Communications
Corrigendum to “Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells” [Cancer Lett. 412 (2018) 297-307]
2023
·
Huong Thuy Le
, Huy Truong Nguyen
, et al.
·
Cancer Letters
Show more works
View as search
Works count:
10
Citation count:
211
H-index:
5
I10-index:
4
Year
Topic
Type